TY - JOUR
T1 - Glucocorticoids, stress and eating
T2 - The mediating role of appetite-regulating hormones
AU - Kuckuck, Susanne
AU - van der Valk, Eline S.
AU - Scheurink, Anton J.W.
AU - van der Voorn, Bibian
AU - Iyer, Anand M.
AU - Visser, Jenny A.
AU - Delhanty, Patric J.D.
AU - van den Berg, Sjoerd A.A.
AU - van Rossum, Elisabeth F.C.
N1 - Funding Information:
EFCvR is supported by a Vidi grant from the Netherlands Organization of Scientific Research, Netherlands Organization of Scientific Research (NWO), grant number: 91716453. EFCvR and BvdV are also funded by the Elisabeth Foundation.
Publisher Copyright:
© 2022 The Authors. Obesity Reviews published by John Wiley & Sons Ltd on behalf of World Obesity Federation.
PY - 2023/3
Y1 - 2023/3
N2 - Disrupted hormonal appetite signaling plays a crucial role in obesity as it may lead to uncontrolled reward-related eating. Such disturbances can be induced not only by weight gain itself but also by glucocorticoid overexposure, for example, due to chronic stress, disease, or medication use. However, the exact pathways are just starting to be understood. Here, we present a conceptual framework of how glucocorticoid excess may impair hormonal appetite signaling and, consequently, eating control in the context of obesity. The evidence we present suggests that counteracting glucocorticoid excess can lead to improvements in appetite signaling and may therefore pose a crucial target for obesity prevention and treatment. In turn, targeting hormonal appetite signals may not only improve weight management and eating behavior but may also decrease detrimental effects of glucocorticoid excess on cardio-metabolic outcomes and mood. We conclude that gaining a better understanding of the relationship between glucocorticoid excess and circulating appetite signals will contribute greatly to improvements in personalized obesity prevention and treatment.
AB - Disrupted hormonal appetite signaling plays a crucial role in obesity as it may lead to uncontrolled reward-related eating. Such disturbances can be induced not only by weight gain itself but also by glucocorticoid overexposure, for example, due to chronic stress, disease, or medication use. However, the exact pathways are just starting to be understood. Here, we present a conceptual framework of how glucocorticoid excess may impair hormonal appetite signaling and, consequently, eating control in the context of obesity. The evidence we present suggests that counteracting glucocorticoid excess can lead to improvements in appetite signaling and may therefore pose a crucial target for obesity prevention and treatment. In turn, targeting hormonal appetite signals may not only improve weight management and eating behavior but may also decrease detrimental effects of glucocorticoid excess on cardio-metabolic outcomes and mood. We conclude that gaining a better understanding of the relationship between glucocorticoid excess and circulating appetite signals will contribute greatly to improvements in personalized obesity prevention and treatment.
KW - appetite regulation
KW - eating behavior
KW - gut-brain axis
KW - HPA axis
UR - http://www.scopus.com/inward/record.url?scp=85144063714&partnerID=8YFLogxK
U2 - 10.1111/obr.13539
DO - 10.1111/obr.13539
M3 - Review article
C2 - 36480471
AN - SCOPUS:85144063714
SN - 1467-7881
VL - 24
JO - Obesity Reviews
JF - Obesity Reviews
IS - 3
M1 - e13539
ER -